12th Global Forum on Nicotine experts fault WHO inaction

Daily Express

6 days ago

Published on: Tuesday, July 22, 2025
Published on: Tue, Jul 22, 2025
By: David Thien Text Size: WARSAW: The World Health Organization (WHO) was taken to task for its refusal to recognise scientific outcomes that prove alternative nicotine products help some 1.3 billion smokers in the world quit the habit, or transition to a less harmful to their health options. This view was shared by many expert participants at the 12th Global Forum on Nicotine (GFN 2025) that was held in Poland at the Warsaw Presidential Hotel from June 19 to 21, 2025. They were scientists and doctors among other professionals. It was reported that smoking causes some 8 million deaths around the world. It is well established that nicotine does not cause smoking-related diseases, which result instead from the inhalation of toxicants in tobacco smoke. High quality independent evidence supporting the role of safer nicotine products in smoking cessation is growing. Vapes, pouches, pasteurised snus and heated tobacco products (HTPs) all deliver nicotine without combustion, leading to substantially reduced health risks in comparison to continued smoking. There was consensus that fear-driven narratives about safer nicotine products means prolonged misery and death for smokers as pervasive misconceptions about safer nicotine products and their role in smoking cessation could see tobacco harm reduction fail to fulfil its huge potential. The Global Forum on Nicotine is organised by Global Forum on Nicotine Limited, an events company committed to providing a platform for global public health debate, knowledge exchange and networking, underpinned by the principles of inclusiveness and multi-sectoral engagement. It does not receive sponsorship from manufacturers, distributors or retailers of nicotine products including pharmaceutical, vaping and tobacco companies. Conference-supporting organisations endorse the event, but have no financial or administrative involvement in organisation of the event. According to Riccardo Polosa, professor of medicine at the University of Catania in Italy, the World Health Organization (WHO) is actively misleading the public about the relative risk of nicotine products compared to cigarettes on purpose. 'They select their references and distort the evidence. There is one single objective, in my opinion, which is to create their own science that supports the abstinence-only narrative,' he says. 'But this has terrible consequences for millions of smokers who would otherwise switch to much less harmful products. In the clinical world, this would be called negligence,' he said, in a special session marked 20 years of the WHO Framework Convention on Tobacco Control (FCTC), in which leading voices examined the treaty's impact. 'The FCTC has succeeded politically and legally,' said Jeannie Cameron, a policy consultant. 'But if we measure success by reductions in smoking and tobacco-related deaths, it has failed.' 'We still have over a billion smokers worldwide. The FCTC was meant to reduce cancer, cardiovascular and respiratory disease,' said Derek Yach, a former WHO director. 'Tobacco harm reduction is the obvious way to stop this crisis in its tracks.' Global experts are tackling a barrier that continues to undermine efforts to reduce the annual 8 million premature deaths related to smoking: misinformation and miscommunication about safer nicotine products and tobacco harm reduction (THR). The GFN 2025 is challenging perceptions as effective communication for tobacco harm reduction conference is a call to action for change. While science increasingly supports safer nicotine products like vapes, snus, pouches and heated tobacco as tools to help smokers switch away from combustibles, fear-driven narratives continue to dominate media and policy. In a keynote lecture Jacob Grier, a journalist covering tobacco policy who has written for Slate and The Atlantic, talked about the disconnect between the evidence for tobacco harm reduction – utility of products like vapes and snus as safer alternatives to continued smoking – and the fact that hostile media narratives are shaping public opinion and health policies. How can impactful, evidence-based messaging be built that respects both reduced-risk products and consumer autonomy? 'Obviously we need to emphasize credible research. The bad news is that having the facts on our side is clearly not enough,' Grier said. 'Journalists seek novelty, so if something isn't new, it isn't news. Millions of people dying from smoking isn't a story, but a few dozen people dying from adulterated [THC or cannabis] vapes generates months of media coverage.' The Global Forum on Nicotine is the only global event that welcomes all stakeholders involved with new and safer nicotine products, including: consumers and consumer advocates; public health experts; policy analysts, parliamentarians and government officials; academics and researchers; product manufacturers and distributors; and media representatives.
Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia